1. Home
  2. AZTA vs LMAT Comparison

AZTA vs LMAT Comparison

Compare AZTA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • LMAT
  • Stock Information
  • Founded
  • AZTA 1978
  • LMAT 1983
  • Country
  • AZTA United States
  • LMAT United States
  • Employees
  • AZTA N/A
  • LMAT N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • LMAT Medical/Dental Instruments
  • Sector
  • AZTA Technology
  • LMAT Health Care
  • Exchange
  • AZTA Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • AZTA 1.8B
  • LMAT 1.8B
  • IPO Year
  • AZTA 1995
  • LMAT 2006
  • Fundamental
  • Price
  • AZTA $34.29
  • LMAT $83.05
  • Analyst Decision
  • AZTA Buy
  • LMAT Buy
  • Analyst Count
  • AZTA 4
  • LMAT 8
  • Target Price
  • AZTA $58.75
  • LMAT $97.00
  • AVG Volume (30 Days)
  • AZTA 737.8K
  • LMAT 285.8K
  • Earning Date
  • AZTA 05-07-2025
  • LMAT 05-01-2025
  • Dividend Yield
  • AZTA N/A
  • LMAT 0.96%
  • EPS Growth
  • AZTA N/A
  • LMAT 44.03
  • EPS
  • AZTA N/A
  • LMAT 1.93
  • Revenue
  • AZTA $662,108,000.00
  • LMAT $219,863,000.00
  • Revenue This Year
  • AZTA N/A
  • LMAT $11.00
  • Revenue Next Year
  • AZTA $5.58
  • LMAT $8.48
  • P/E Ratio
  • AZTA N/A
  • LMAT $43.03
  • Revenue Growth
  • AZTA 5.36
  • LMAT 13.63
  • 52 Week Low
  • AZTA $33.37
  • LMAT $62.39
  • 52 Week High
  • AZTA $63.58
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 30.18
  • LMAT 39.01
  • Support Level
  • AZTA $35.06
  • LMAT $82.52
  • Resistance Level
  • AZTA $38.57
  • LMAT $85.50
  • Average True Range (ATR)
  • AZTA 1.73
  • LMAT 2.49
  • MACD
  • AZTA 0.06
  • LMAT 0.44
  • Stochastic Oscillator
  • AZTA 4.11
  • LMAT 53.32

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: